journal article·2025-06

Fluorescent Nanoparticle Drug Delivery System Based on Polymer-Silicon Materials and Its Synergistic Effects in Osteoarthritis

Yu-Hao Cui, Gang Hou, Jin-Yi Zhu

Silicon· Volume 17· Issue 8
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Supramolecular Self-Assembly in Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (21)

Show source-provided references
1. Curković B (2005) Pharmacotherapy of osteoarthritis. Reumatizam 52:47–51
2. Aubourg G, Rice SJ, Bruce-Wootton P, Loughlin J (2022) Genetics of osteoarthritis. Osteoarthr Cartilage 30:636–64910.1016/j.joca.2021.03.002 ↗
3. Buchanan WW, Kean CA, Kean WF, Rainsford KD (2024) Osteoarthritis. Inflammopharmacology 32:13–2210.1007/s10787-023-01223-y ↗
4. Claassen A, Koëter S, Botman J, Schers H, van den Ende C (2016) FRI0645-HPR frequently asked questions of patients with osteoarthritis: A consensus exercise. Ann Rheum Dis 75:128710.1136/annrheumdis-2016-eular.2140 ↗
5. Cokelaere SM, Plomp SGM, de Boef E, de Leeuw M, Bool S, van de Lest CHA, van Weeren PR, Korthagen NM (2018) Sustained intra-articular release of celecoxib in an equine repeated LPS synovitis model. Eur J Pharm Biopharm 128:327–33610.1016/j.ejpb.2018.05.001 ↗
6. Cooke JP, Ferrari M (2018) Inflammation-targeted vascular nanomedicine. Nat Biomed Eng 2:269–27010.1038/s41551-018-0241-y ↗
7. De Roover A, Escribano-Núñez A, Monteagudo S, Lories R (2023) Fundamentals of osteoarthritis: Inflammatory mediators in osteoarthritis. Osteoarthr Cartilage 31:1303–131110.1016/j.joca.2023.06.005 ↗
8. Driban JB, Harkey MS, Liu SH, Salzler M, McAlindon TE (2020) Osteoarthritis and aging: Young adults with osteoarthritis. Curr Epidemiol Rep 7:9–1510.1007/s40471-020-00224-7 ↗
9. Easwaran R, Mistry UK, Bhole M, Peethambaran K (2024) Polmacoxib: A Review of the newer non-steroidal anti-inflammatory drug in osteoarthritis. Cureus 16:e58446
10. El-Gogary RI, Khattab MA, Abd-Allah H (2020) Intra-articular multifunctional celecoxib loaded hyaluronan nanocapsules for the suppression of inflammation in an osteoarthritic rat model. Int J Pharmaceut 583:11937810.1016/j.ijpharm.2020.119378 ↗
11. Elakkad YE, Younis MK, Allam RM, Mohsen AF, Khalil IA (2021) Tenoxicam loaded hyalcubosomes for osteoarthritis. Int J Pharmaceut 601:12048310.1016/j.ijpharm.2021.120483 ↗
12. Rejeeth C, Vivek R, NipunBabu V, Sharma A, Ding X, Qian K (2017) Cancer nanomedicine: from PDGF targeted drug delivery. MedChemComm 8:2055–205910.1039/C7MD00391A ↗
13. Savvidou O, Milonaki M, Goumenos S, Flevas D, Papagelopoulos P, Moutsatsou P (2019) Glucocorticoid signaling and osteoarthritis. Mol Cell Endocrinol 480:153–16610.1016/j.mce.2018.11.001 ↗
14. Shah A, Aftab S, Nisar J, Ashiq MN, Iftikhar FJ (2021) Nanocarriers for targeted drug delivery. J Drug Deliv Sci Technol 62:10242610.1016/j.jddst.2021.102426 ↗
15. Srinivasarao M, Low PS (2017) Ligand-targeted drug delivery. Chem Rev 117:12133–1216410.1021/acs.chemrev.7b00013 ↗
16. Wang Q, Yang X, Gu X, Wei F, Cao W, Zheng L, Li Y, Ma T, Wu C, Wang Q (2022) Celecoxib nanocrystal-loaded dissolving microneedles with highly efficient for osteoarthritis treatment. Int J Pharm 625:12210810.1016/j.ijpharm.2022.122108 ↗
17. Woythe L, Tito NB, Albertazzi L (2021) A quantitative view on multivalent nanomedicine targeting. Adv Drug Deliv Rev 169:1–2110.1016/j.addr.2020.11.010 ↗
18. Wu Y, Sun B, Tang Y, Shen A, Lin Y, Zhao X, Li J, Monteiro MJ, Gu W (2024) Bone targeted nano-drug and nano-delivery. Bone Res 12:5110.1038/s41413-024-00356-2 ↗
19. Xu C, Gu K, Yasen Y, Hou Y (2016) Efficacy and safety of celecoxib therapy in osteoarthritis: A meta-analysis of randomized controlled trials. Medicine 95:e358510.1097/MD.0000000000003585 ↗
20. Bhole RP, Joshi GO, Kapare HS, Chikhale RV, Chaudhari S (2024) Covalent drug – An emerging framework for targeted drug development. Results Chem 8:10161510.1016/j.rechem.2024.101615 ↗
21. Brown S, Kumar S, Sharma B (2019) Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. Acta Biomater 93:239–25710.1016/j.actbio.2019.03.010 ↗